Broadfin Capital
Latest statistics and disclosures from Broadfin Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, IWM, Biohaven Pharmaceutical Holding, XBI, BioDelivery Sciences International, and represent 52.16% of Broadfin Capital's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$133M), ALKS (+$20M), STAA (+$16M), Quotient (+$13M), LNTH (+$13M), NSTGQ (+$12M), Vapotherm (+$12M), VRAYQ (+$11M), La Jolla Pharmaceuticl Com Par (+$9.8M), Alexion Pharmaceuticals (+$9.0M).
- Started 11 new stock positions in Scynexis, Mylan Nv, ANAB, Luminex Corporation, STAA, LNTH, AUPH, RLMD, Alexion Pharmaceuticals, IWM. Vapotherm.
- Reduced shares in these 10 stocks: XBI (-$33M), IOVA (-$17M), Allergan (-$16M), Flamel Technologies Sa (-$16M), Mirati Therapeutics (-$16M), NVRO (-$13M), Wright Medical Group Nv (-$13M), , AMRN (-$11M), Global Blood Therapeutics In (-$8.6M).
- Sold out of its positions in ADMA, AMAG Pharmaceuticals, ABBV, Antares Pharma, CPRX, XGN, Gw Pharmaceuticals Plc ads, Global Blood Therapeutics In, Mirati Therapeutics, NVRO. Retrophin, SIBN, Allergan, Strongbridge Bioph shs usd, Wright Medical Group Nv.
- Broadfin Capital was a net buyer of stock by $83M.
- Broadfin Capital has $747M in assets under management (AUM), dropping by 38.07%.
- Central Index Key (CIK): 0001511901
Tip: Access up to 7 years of quarterly data
Positions held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 38 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 19.0 | $142M | 440k | 321.86 |
|
|
| iShares Russell 2000 Index (IWM) | 17.8 | $133M | NEW | 800k | 165.67 |
|
| Biohaven Pharmaceutical Holding | 7.4 | $55M | -2% | 1.0M | 54.44 |
|
| SPDR S&P Biotech (XBI) | 4.5 | $33M | -50% | 350k | 95.11 |
|
| BioDelivery Sciences International | 3.6 | $27M | 4.3M | 6.32 |
|
|
| Alkermes (ALKS) | 3.4 | $25M | +395% | 1.2M | 20.40 |
|
| Viewray (VRAYQ) | 3.1 | $24M | +85% | 5.6M | 4.22 |
|
| Amarin Corporation (AMRN) | 3.0 | $23M | -33% | 1.0M | 21.44 |
|
| Quotient | 2.5 | $19M | +225% | 2.0M | 9.51 |
|
| Eiger Biopharmaceuticals | 2.5 | $18M | -9% | 1.2M | 14.90 |
|
| STAAR Surgical Company (STAA) | 2.2 | $16M | NEW | 462k | 35.17 |
|
| Intersect Ent | 2.1 | $16M | -19% | 631k | 24.90 |
|
| Progenics Pharmaceuticals | 2.1 | $16M | +93% | 3.1M | 5.09 |
|
| Nanostring Technologies (NSTGQ) | 2.1 | $16M | +401% | 556k | 27.82 |
|
| Iovance Biotherapeutics (IOVA) | 2.0 | $15M | -52% | 533k | 27.68 |
|
| Dermira | 1.8 | $14M | +54% | 896k | 15.16 |
|
| Recro Pharma | 1.8 | $13M | -26% | 721k | 18.33 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $13M | NEW | 618k | 20.51 |
|
| Vapotherm | 1.6 | $12M | NEW | 1.0M | 12.16 |
|
| Sientra | 1.5 | $12M | -35% | 1.3M | 8.94 |
|
| Vericel (VCEL) | 1.4 | $11M | +161% | 620k | 17.40 |
|
| La Jolla Pharmaceuticl Com Par | 1.4 | $11M | +1378% | 2.7M | 3.93 |
|
| Alexion Pharmaceuticals | 1.2 | $9.0M | NEW | 83k | 108.15 |
|
| Sol Gel Technologies (SLGL) | 1.2 | $8.9M | -7% | 522k | 17.15 |
|
| Relmada Therapeutics (RLMD) | 1.1 | $8.6M | NEW | 221k | 39.00 |
|
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $8.1M | NEW | 400k | 20.26 |
|
| Flamel Technologies Sa | 1.0 | $7.8M | -66% | 1.0M | 7.55 |
|
| Exicure | 1.0 | $7.7M | +17% | 2.7M | 2.86 |
|
| Zogenix | 0.9 | $7.0M | -2% | 135k | 52.13 |
|
| ICU Medical, Incorporated (ICUI) | 0.8 | $5.6M | 30k | 187.13 |
|
|
| Luminex Corporation | 0.6 | $4.8M | NEW | 208k | 23.16 |
|
| Strata Skin Sciences | 0.5 | $3.8M | -36% | 1.8M | 2.08 |
|
| Aclaris Therapeutics (ACRS) | 0.5 | $3.6M | +16% | 1.9M | 1.89 |
|
| Anaptysbio Inc Common (ANAB) | 0.5 | $3.6M | NEW | 222k | 16.25 |
|
| Mylan Nv | 0.4 | $3.0M | NEW | 150k | 20.10 |
|
| Heron Therapeutics (HRTX) | 0.3 | $2.1M | -54% | 90k | 23.50 |
|
| Scynexis | 0.2 | $1.8M | NEW | 2.0M | 0.91 |
|
| Palatin Technologies | 0.1 | $817k | 1.0M | 0.78 |
|
Past Filings by Broadfin Capital
SEC 13F filings are viewable for Broadfin Capital going back to 2010
- Broadfin Capital 2019 Q4 filed Feb. 14, 2020
- Broadfin Capital 2019 Q3 filed Nov. 14, 2019
- Broadfin Capital 2019 Q2 filed Aug. 14, 2019
- Broadfin Capital 2019 Q1 filed May 15, 2019
- Broadfin Capital 2018 Q4 filed Feb. 14, 2019
- Broadfin Capital 2018 Q3 filed Nov. 14, 2018
- Broadfin Capital 2018 Q2 filed Aug. 14, 2018
- Broadfin Capital 2018 Q1 filed May 14, 2018
- Broadfin Capital 2017 Q4 filed Feb. 13, 2018
- Broadfin Capital 2017 Q3 filed Nov. 14, 2017
- Broadfin Capital 2017 Q2 amended filed Aug. 17, 2017
- Broadfin Capital 2017 Q2 filed Aug. 14, 2017
- Broadfin Capital 2017 Q1 filed May 15, 2017
- Broadfin Capital 2016 Q4 filed Feb. 14, 2017
- Broadfin Capital 2016 Q3 filed Nov. 14, 2016
- Broadfin Capital 2016 Q2 filed Aug. 15, 2016